With 2019 right around the corner, three key themes stand out far beyond any other topics that will shape the business end of the marijuana industry. That includes perhaps the most shocking emerging target demographic for cannabis to date.
There is a reason the adage "you get what you pay for" exists. Dozens of financial information websites put out a lot of misleading information, especially when it comes to cannabis companies that are new or making a lot of deals.
Stocks are likely to post much bigger gains when the possibility of something (e.g., a law change, a merger or acquisition, etc.) first becomes known. Once the event actually happens, many investors have already moved on or may even be looking to take some gains (sell off the stocks they bought in advance of or right as a rumor came out). Three new indices show this very thing.
The best emerging cannabis stock opportunities right now don’t involve companies listed on the New York Stock Exchange or Nasdaq. Fortunately, most of the biggest U.S-based brokers now allow you to trades stocks listed in Canada, notably ones on the Toronto Stock Exchange (TSX) and the Canadian Securities Exchange (CSE).
More than $42 billion is spent annually on medical and psychiatric care. And with treatments like opioids increasingly out of favor, Americans - especially veterans suffering from PTSD - are looking for safe, reliable alternatives. And cannabis more than any other substance is ready to fill that void.
When downturns hit a cannabis stock, that can be a good thing - It creates opportunity following the immediacy of the bad news. Even investing legends will tell you that it's a fool's errand trying to pick the exact lowest price as the only time to get in on a stock.
It's time to add two more cannabis names to the NYSE scoreboard. This week, two of the big five Canadian producers join their fellow colleagues in migrating to a massive U.S. exchange - a trend our Executive Director isn't expecting to stop anytime soon. But that doesn't mean investors should rush out and snap up shares. Instead, he's got his eyes on a few other up-and-comers that offer even greater potential.
Starting today, the game for Canadian cannabis producers has changed forever. Now that Canada's "Green Wednesday" has come and gone, NICI's Executive Director is ready to reveal what you can expect from the first "post-legalization" Canadian market. Better yet, he'll show you where you can find some great, actionable "buy" signals.
The cannabis IPO wave has overtaken the United States, and there's a massive payday in store for investors riding it. Today, we're going to give you an inside look at the kind of profit-making potential at stake here.